medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Impact of public health interventions on the COVID-19 epidemic: a stochastic model based on
data from an African island
Dr. D. C. Nuckchady1
1

Specialist in Internal Medicine and Infectious Diseases, Department of Internal Medicine, Dr. A. G. Jeetoo

Hospital, Port-Louis, Mauritius
Abstract
A stochastic model was created to simulate the impact of various healthcare measures on the COVID-19
epidemic. Travel restrictions and point of entry or exit screening help to delay the onset of the outbreak
by a few weeks. Population surveillance is critical to detect the start of community transmission early and
to avoid a surge in cases. Contact reduction and contact tracing are key interventions that can help to
control the outbreak. To promptly curb the number of new cases, countries should diagnose patients
using a highly sensitive test.
Introduction
The effects of various public health strategies to halt the progression of Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) are uncertain. This article discusses a simple mathematical and
epidemiological model that simulates the transmission of SARS-CoV-2 in Mauritius. The outcomes of
various testing strategies, contact tracing, point of entry screening, effective contact reduction and
population-based surveillance are estimated using this model.
Methods
Stochastic modeling is utilized in this article instead of a deterministic one since stochastic models are
known to fail less often (1). Initially, a population of fixed size is assumed to be entirely susceptible to
SARS-CoV-2. Infected people can enter the country at a pre-determined rate. Symptomatic patients visit
a healthcare center and get tested. Those patients who are tested positive are isolated and started on
treatment. If the test is negative, a repeat test is done â€“ each patient can undergo a maximum of 2 tests.
The threshold for testing each patient varies depending on the severity of his / her symptoms. Patients
who die or who become immune to the disease are removed from the set of susceptible persons;
however, a proportion of patients will not mount a proper immune response and will remain susceptible
to the disease according to the model.

1
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Several measures can be undertaken by the country to reduce the burden of SARS-CoV-2. These are travel
restrictions, point of entry screening using questionnaires and non-contact thermometers, increasing the
number of tests being done in the population, iterative contact tracing, quarantining all contacts and
persons who fail the screening test, and putting in place strategies to effectively reduce contacts. The
latter is not limited to community lockdown, broad confinement and universal curfew; any techniques
that may be effective in reducing transmission of the disease during contacts can be considered e.g.
unrestricted wearing of masks, prevalent hand hygiene, social distancing and proper cough etiquette. In
most countries, such measures are intensified after the first few cases of COVID-19 have been diagnosed.
Figure 1 describes the schema used in the model. Patients who are isolated or in quarantine can still
transmit the disease but at a much lower rate. The values of the variables used in the standard model are
shown in table 1. The justification for employing these numbers is provided in section A of the
accompanying appendix. Additional assumptions that were made in the model are specified in section B
while the mathematical details are described in section C. The values were fitted to give a mean basic
reproductive number R0 of 2.8 (mean Î¼ = 2.8, standard deviation Ïƒ = 0.065) and a mean case fatality rate
of 2.8% (Ïƒ = 0.64%); the model was fitted to match the number of cases of COVID-19 diagnosed in
Mauritius from 18 March till 12 April 2020.
The model was run 100 times for 99 days to obtain the mean, standard deviation, and range of several
variables. Multiple sensitivity analyses were conducted to ensure the results were robust. The software
utilized were Excel 2003 (build 12624.20466 Click-to-Run), Java version 8 (update 181; build 1.8.0_181b13) run on Eclipse Mars (4.5.0) and R version 3.6.1. The values of various parameters are provided in the
text to within 2 significant figures.
Results
How well does the model resemble actual data?
Figures 2 and 3 illustrate that the model is able to simulate the actual number of diagnoses that occurred
in Mauritius well.
However, for the model to fit reality well, infections had to have started in the country 3 to 4 weeks prior
to the first case being diagnosed (figure 4). This is not entirely surprising since deaths occurred soon after
the first case was diagnosed, but a period of about 18 days will lapse from the time of exposure to the
time of death since, based on data from China, the time from admission to death is 13 days and the time
for patients to get diagnosed and admitted is slightly more than the incubation period of 5 days (2). Hence,
2

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

transmission had to occur many days before the first death. Sporadic cases may have occurred even earlier
without causing significant community transmission, a situation that appears to have occurred in the USA
and in France (3, 4).
The model predicts that the actual number of infections in the country was about 9 times higher than the
number diagnosed (Î¼ = 8.6, Ïƒ = 7.1). Moreover, the infection fatality rate was 2.3 times less than the
measured case fatality rate of 2.8%.
The effects of individual public health strategies were determined from the model by examining different
scenarios.
Can testing symptomatic patients extensively stop the epidemic?
Effects on the progression of the epidemic can be measured using the effective reproductive number (R e).
To make the model useful in practical terms across several countries, a diagnostic rate D was defined as
follows:
ð· =

ð‘ð‘¢ð‘šð‘ð‘’ð‘Ÿ ð‘œð‘“ ð‘¡ð‘’ð‘ ð‘¡ð‘  ð‘ð‘’ð‘Ÿð‘“ð‘œð‘Ÿð‘šð‘’ð‘‘
ð‘ð‘¢ð‘šð‘ð‘’ð‘Ÿ ð‘œð‘“ ð‘ð‘Žð‘ ð‘’ð‘  ð‘‘ð‘–ð‘Žð‘”ð‘›ð‘œð‘ ð‘’ð‘‘

Hence, if a country diagnosed 20 new cases yesterday and performs 100 tests today, D = 5 tests per case.
In the model, the least value of D was 1/10,000th the population size.
Even if the test used is 100% sensitive (S = 100%) and 100% of symptomatic patients get tested (F = fraction
tested = 100%), Re decreases by a maximum of only 20%, a drop that occurs when D is more than 250
tests per case. For instance, when the USA had 1.5 million cases of Coronavirus Disease 2019 (COVID-19),
SARS-CoV-2 patients were already identified for about 116 days in the country; for maximum effect, about
3 million tests should have been carried out per day during that period (

,

,

âˆ™

), a value similar to

that found in another study (5).
However, such efforts would still be insufficient to halt the epidemic since many infections are transmitted
via asymptomatic or pre-symptomatic carriers i.e. Re would remain above 1.
Can mass screening of the population stop the epidemic?
In this scenario, the whole population, including asymptomatic patients, gets tested. Because mass testing
will drop the positivity rate significantly, the lower limit of this rate was decreased from 0.5% to 0.25% in
the model.

3

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

In the first instance, assume everyone will get tested only once while asymptomatic. Even when S and F
are 100%, Re drops by at most 30% when D is greater than 500 tests per diagnosis. The reason this strategy
appears ineffective is (a) a large proportion of the population cannot get tested rapidly enough, meaning
that some infected people will be detected later on, after they have transmitted the disease, and (b)
people who have tested negative previously and are now infected, will no longer be tested, unless and
until they develop symptoms i.e. they are able to propagate the disease during the pre-symptomatic
phase.
We may consider another strategy: asymptomatic individuals can be tested at regular intervals for any
number of times. Assuming S and F are once again 100%, R e can be decreased by more than 80% when D
is more than 900 tests per diagnosis; this will give a value of Re of less than 1, effectively stopping the
epidemic. However, assuming a more realistic value of F = 40% and S = 75%, R e declines by less than 20%.
In other words, mass screening only works if a large fraction of the population can get tested at regular
intervals with a highly sensitive test.
What is the effect of contact tracing on the epidemic?
In this scenario, the test sensitivity (S) is assumed to be 75%. Symptomatic people are tested at the same
frequency as stated in the standard model (i.e. mean F = 22%). Iterative backward contact tracing is
applied in the model and contacts are traced within 72 hours; this simulation traces all individuals who
were in contact with the patient for the duration of an incubation period. However, note that the World
Health Organization (WHO) recommends tracing people who were in contact with patients for only 48
hours before symptom onset (6).
Even when 100% of contacts are traced, Re decreases by at most 15% when D is larger than 250 tests per
case. This can be explained by (a) the test misses several cases due to its low sensitivity, (b) insufficient
tests are performed among symptomatic cases and (c) it takes several days to complete contact tracing.
Of note, forward with backward tracing does not improve the results significantly.
However, if S and F are 100%, and all contacts are traced within 1 day (instead of 3 days), R e can drop by
about 50% (Î¼ = 55%, Ïƒ = 15%) if tracing starts 4 weeks after the outbreak (and D > 250 tests / case);
moreover, if tracing starts within 2 weeks of the outbreak, R e decreases by 80% (Î¼ = 80%, Ïƒ = 13%), which
is enough to stop the epidemy.

4

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Put in simple terms, test and trace works if the test is highly sensitive, when a large number of tests are
performed, when most contacts can be traced and when it is started soon after the outbreak is identified.
How much effective contact reduction is necessary to reduce R e to below 1?
A 70% reduction in contacts has a 50% chance of reducing Re to less than 1 provided the measures are
taken within 14 days of the start of the outbreak and the entire population is 100% compliant. R e stays
low independent of the number of tests conducted, the sensitivity of the test, the fraction of people tested
and the extent of contact tracing. This is similar to what is expected from herd immunity (i.e. 1 âˆ’

). If

universal contact reduction measures are implemented 28 days after the start of the outbreak, then, an
80% reduction in contacts is required, similar to what has been reported in another paper (7), to control
the epidemic in less than 2 months. If compliance is not 100%, even more reduction becomes necessary.
For how long should strict contact reduction be imposed?
It may not be realistic in most situations to severely limit contacts for prolonged periods of time e.g. via
confinement. Assuming that no newly infected people enter the country, if everything returns back to
normal (i.e. there is no contact reduction) 3 days after registering no new diagnoses, there is virtually a
100% chance of a new diagnosis within 2 days (Î¼ = 2.2, Ïƒ = 0.97) i.e. a second wave is guaranteed to occur.
Returning to normal 7 days after having no cases leads to a 76% chance of getting a new case within 5
days (Î¼ = 4.9, Ïƒ = 4.2) while waiting for 14 days reduces the risk of recurrence to 28%. When the epidemy
does recur in the latter scenario, it does so within 5 days also (Î¼ = 5.4, Ïƒ = 5.5).
By estimating the daily Re using various techniques (8, 9), a phased weakening of measures can be
implemented; for instance when the Re is consistently below 2, only a 50% reduction in contacts is
necessary (= 1 âˆ’

). This can help to gradually ease restrictions without letting the outbreak go out of

control.
The chance of a second wave is non-negligible, a point that has been demonstrated by many other models
in the literature. If lockdown is the primary strategy that is used by a country to stop the epidemy, it should
remain in place for more than 14 days after no cases have been diagnosed, if practically and economically
feasible.
How does point of entry screening affect the start of the epidemic?

5

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Assuming 1 infected person enters the country per day and the sensitivity of point of entry or exit (POE)
screening is 64%, there is almost a 100% that an epidemy will break out within 10 days (Î¼ = 9.7, Ïƒ = 2.8).
Even if the POE screening is 100% sensitive, outbreaks will still occur, but this will take longer to occur (Î¼
= 20 days, Ïƒ = 10). No screening leads to an outbreak within 6 days.
POE can delay the start of outbreaks by about 2 to 3 mean incubation periods, but it does not stop
outbreaks from happening, a point that has been made by other authors (10). Questionnaires and
thermometers are usually inadequate (11) and for practical reasons, results of tests should be rapidly
available at entry points.
What is the effect of travel restrictions?
By reducing the entry of infected passengers to 1 person with SARS-CoV-2 entering the country every 100
days, the probability of an outbreak occurring is reduced to only 10% (over 3 months) if the sensitivity of
POE screening is 100%, and to 48% if the sensitivity is 50%. However, if an epidemy does break out, it is
likely to do so within the first 1 to 3 weeks.
Once again, travel restrictions serve to delay the onset of the epidemic, not to stop it entirely. Such
restrictions work best when cases are identified and isolated promptly, thus preventing transmission to
the community. Thompson found a risk of 41% of sustained transmission in the community from a single
imported case but this risk can be reduced to 1.2% when surveillance is substantially improved (12).
What would be the utility of population surveillance?
Suppose that a country decides to test all of its Severe Acute Respiratory Infection cases (SARI) for SARSCoV-2 before an epidemy starts without regard to epidemiological criteria (i.e. even when the patients do
not have a relevant travel or contact history). As soon as it detects its first community-acquired case, it
will start all the measures as stated in the standard model i.e. travel restrictions, contact tracing,
quarantine, and contact reduction.
Compared to the standard model, this strategy detects the first case sooner (at day 2 instead of day 28).
The first community transmission is observed at 15 days and subsequently, the mean total number of
infections at 28 days in the country is about 6 times less.
Population surveillance serves as an early warning alert and response system to allow the country to take
actions quickly and to prevent a surge from happening. Countries that use mostly epidemiologic
surveillance (i.e. test only travelers from high risk regions) instead of syndromic surveillance will fail to
6

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

detect cases in a timely manner mostly because (a) some travelers may hide their symptoms and therefore
not get tested, (b) tests are imperfect and will miss some cases among travelers and (c) pre-symptomatic
transmission can happen before the traveler is diagnosed and isolated.
What if contact reduction is not followed by a portion of the population?
Underprivileged people may not be able to remain confined for a long period of time. In this part of the
model, 10% of the population continues to have twice more contacts than the remainder of the country
despite strict contact reduction measures being implemented. Under such circumstances, the probability
of the epidemy â€˜endingâ€™ within 99 days (i.e. reaching consecutive 3 to 14 days without any cases)
decreases by 3 to 10 times when compared to the standard model.
This implies that compliance to universal contact reduction measures is critical for success. The less
compliant part of the population can act as reservoirs and re-introduce infections which will prevent the
outbreak from ending.
Discussion
In a disease that can spread effectively during the pre-symptomatic phase, large-scale testing of
symptomatic patients will not stop the epidemy. However, testing remains important to identify at-risk
individuals who may benefit from treatment.
On the other hand, universal screening of asymptomatic individuals can help halt the progress of the
outbreak, but it may not be cost-effective since a large proportion of the population must be regularly
tested, and it requires a test with sensitivity greater than 90%. This may not be practical on its own.
While early, backward, iterative contact tracing together with comprehensive testing of symptomatic
cases and quarantining of contacts can have significant effects on the incidence curve, this is still
insufficient to decrease the effective reproductive number below 1 especially if the R e is more than 5.
When examining a more realistic situation in which 80% of contacts are traced, the sensitivity of the test
is 90%, 90% of symptomatic patients get tested and test and trace starts 2 weeks after the first infected
person enters the country, this strategy will work only if Re is less than 2. Ideally, test and trace should be
combined with other strategies in order to be successful, a finding that is confirmed by other authors (13).
Once the exponential phase of the outbreak starts, in virtually all scenarios where R e is above 2 and
detection of community transmission is delayed by more than 2 weeks, universal contact reduction
strategies are required to stop a surge. Since lockdowns are not economically viable, it is imperative for
7

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

countries to invest in what are sometimes viewed as inconvenient measures like social distancing and
universal masking. The objective is to reduce the risk of transmission per contact or the number of
contacts per person to such a low value that the epidemy will halt. For instance, preliminary evidence
indicate that physical distancing or masking may reduce transmission risk by 60% to more than 80% (14),
which suggest these measures may work well if Re is less than 3 to 5.
Such contact reduction techniques should be continued for as long as possible until after the outbreak
dies out, preferably 28 days after the last case was diagnosed since this reduces the risk of a second wave
to less than 10%. However, it may not be economically feasible to maintain universal contact reduction
measures for a prolonged period and relaxation of these measures can be entertained as long as the
estimated daily Re is gradually decreasing; a strong test and trace system will ensure that R e does not rise
again.
In a situation where most parts of the world are still being challenged by COVID-19, re-importation of the
disease is highly likely once the lockdown is eased; many models suggest that flattening the curve using
lockdowns can delay the peak of the epidemy but the total number of infections remain the same or in
worst case scenarios, it may even increase if lockdowns are started too late (15). While lockdowns can
provide precious time initially to prepare the public and the healthcare system to face the disease, this is
a reasonable long-term solution only if the lockdown is relaxed when (a) herd immunity is reached e.g.
via effective vaccination with minimal side effects and long-term protection or (b) the country no longer
registers new cases and its borders can remain closed until most parts of the world have controlled the
epidemic. If these conditions are unlikely to be met (e.g. in the case of a widespread pandemic during
which Re is greater than 1 in many countries and worldwide collaboration appears inadequate to bring the
global Re below 1 rapidly), some epidemiologists have advocated the use of controlled herd immunity
which can be successful if (a) most patients become immune to the disease on recovery, (b) the vulnerable
part of the population can be adequately protected from the infection and (c) the infection is not allowed
to surge so as not to overwhelm the health services and also to give enough time for neutralising
antibodies to form. Although controlled herd immunity was not thoroughly assessed in this model,
assuming functional antibodies take 14 days to form, Re should be maintained between 1.0 and 1.7 for
this strategy to work â€“ it can take several months to years to reach herd immunity thus. Sweden may have
failed in using this strategy partly because it did not reduce its R e sufficiently (e.g. via extensive contact
tracing) and it did not protect the frail segment of its population appropriately.

8

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

To minimize the risk of a second wave from imported cases, all individuals entering the country should
undergo POE screening. Alone, this is unlikely to have a substantial impact, especially since current tests
have less than 90% sensitivity. Some form of travel restrictions should also be considered if the country is
currently not well prepared to face a second wave. Travelers may be allowed to enter the country if they
come from an area with a low prevalence of the disease.
Once the epidemy is over, an early warning system is of paramount importance. This may involve sentinel
surveillance, random population screens and / or testing patients with influenza-like illness or SARI for
SARS-CoV-2. Once again, it is necessary to ensure that the quality of the test is good or else too many
cases will be missed. While the model emphasizes the significance of sensitivity, specificity is equally
salient; doing a test with poor specificity on many patients will lead to frequent false positives that can
drain resources from the healthcare system.
In many countries, the destitute and needy may not have access to masks or alcohol sanitizers. They live
in crowded areas like slums and ghettos. Such conditions can encourage the transmission of SARS-CoV-2.
By accounting for this segment of the population in the model, it was shown that neglecting this group of
people leads to a slower decline in the epidemy â€“ equality of access to healthcare is crucial.
Figures 5 and 6 illustrate some key steps that should be taken by a country when facing an outbreak from
primarily a respiratory illness like COVID-19. These can help countries develop appropriate policies. Some
fundamental points must be emphasized:
ï€­

Deciding which outbreaks are concerning enough to trigger potentially economically ruinous
interventions is not easy. Most countries rely on the WHO to declare a Public Health Emergency
of International Concern, but the algorithm that the WHO uses should be improved (16).

ï€­

Equally problematic is determining when an outbreak is getting out of control. An overwhelmed
healthcare system is associated with a higher mortality. Swift and decisive actions must be
adopted by the country under such circumstances to mitigate the damage. A short doubling time
of the number of cases together with a sharp drop in the number of beds available in hospitals
should be cause for concern.

Had Mauritius followed the steps in figure 5 rigorously, the country would have seen 6 times less cases of
COVID-19 and virtually zero deaths.
Even though all models are ultimately wrong and all countries are facing their own challenges, I hope that
the model that was utilized in this article has highlighted the importance of good population surveillance
9

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

and the need to keep a low number of contacts for an extended duration of time. Furthermore, it is a
priority to look for an affordable diagnostic test for SARS-CoV-2 that is more than 90% sensitive and
specific.

10

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

References
1.
2.
3.
4.
5.

6.
7.
8.
9.
10.
11.
12.
13.

14.

15.
16.

Kobayashi, Hisashi. (2020). Stochastic Modeling of an Infectious Disease, Part I: Understand the Negative
Binomial Distribution and Predict an Epidemic More Reliably. Preprint. https://arxiv.org/abs/2006.01586
Wang L, Li J, Guo S, et al. Real-time estimation and prediction of mortality caused by COVID-19 with patient
information based algorithm. Sci Total Environ. 2020;727:138394.
https://www.livescience.com/covid-19-like-illness-december-washington.html Accessed June 2020
Deslandes A, Berti V, Tandjaoui-Lambotte Y, et al. SARS-CoV-2 was already spreading in France in late
December 2019. Int J Antimicrob Agents. 2020;55(6):106006.
Allen D, Block S, Cohen J et al. Roadmap to pandemic resilience: Massive Scale Testing, Tracing, and
Supported Isolation (TTSI) as the Path to Pandemic Resilience for a Free Society. Edmond J. Safra Center for
Ethics at Harvard University. April 20, 2020.
World Health Organization. Contact tracing in the context of COVID-19. Interim guidance. 10 May 2020.
Francisco J. Perez-Reche, Ken J. Forbes, Norval J. C. Strachan. Importance of untested infectious individuals
for the suppression of COVID-19 epidemics. medRxiv 2020.04.13.20064022. Preprint.
Pandit JJ. Managing the R0 of Covid-19: mathematics fights back [published online ahead of print, 2020 May
28]. Anaesthesia. 2020;10.1111/anae.15151.
Contreras S, Villavicencio H, Medina-Ortiz D et al. (2020). Real-time estimation of R 0 for supporting publichealth policies against COVID-19. medRxiv 2020.04.23.20076984. Preprint.
Cowling BJ, Lau LL, Wu P, et al. Entry screening to delay local transmission of 2009 pandemic influenza A
(H1N1). BMC Infect Dis. 2010;10:82. 2010 Mar 30.
Quilty BJ, Clifford S, Cmmid nCoV Working Group, Flasche S and Eggo RM. Effectiveness of airport screening
at detecting travellers infected with novel coronavirus (2019-nCoV). Euro Surveill. 2020 Feb;25(5).
Thompson RN. Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for
Preventing Sustained Transmission in New Locations. J Clin Med. 2020 Feb 11;9(2).
Emma L Davis, Tim C D Lucas, Anna Borlase et al. An imperfect tool: COVID-19 'test & trace' success relies
on minimising the impact of false negatives and continuation of physical distancing. medRxiv
2020.06.09.20124008. Preprint.
Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-toperson transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis [published online
ahead of print, 2020 Jun 1]. Lancet. 2020;S0140-6736(20)31142-9.
Alain Debecker and Theodore Modis. Poorly known aspects of flattening the curve of COVID-19. medRxiv
2020.06.09.20126128. Preprint.
Durrheim DN, Gostin LO, Moodley K. When does a major outbreak become a Public Health Emergency of
International Concern? [published online ahead of print, 2020 May 19]. Lancet Infect Dis. 2020;S14733099(20)30401-1.

11

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Susceptible population

Infected entries into the
country

Point of entry screening
Positive

Negative

Quarantined

Community transmission

Contact tracing

Some people get tested

2 tests per person at most
Positive

Isolated and treated

Cured and immune

Dead

Negative

Cured but remains
susceptible

Figure 1: A simple schema to illustrate the model utilized in this article.

12

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Variable

Value

Population size

1,200,000 people

Rate of entry of infected people*

1 person per day for D* days; then 0 infected person
per day enters the country

Sensitivity of point of entry screening

64%

Probability a person will transmit the infection*

~N(0.03, 0.04); lower limit = 0.01; upper limit = 1

Number of contacts per person per day in the
community without contact reduction

~N(13, 9); lower limit = 0 contacts

Contact reduction during quarantine

Reduced by 90%

Contact reduction during isolation

Reduced by 95%

Contact reduction when universal contact reduction
measures are taken*

20% reduction for 7 days after D days; then 80%
reduction; essential workers have 50% more contacts
when such measures are being undertaken

% of population that are essential workers

1.0%

Sensitivity of test for SARS-CoV-2

75%. Test results are available on the same day.

% of infected patients who remain susceptible to the
virus

14%

% of contacts that are successfully traced*

25% for 7 days after D days; then 70%

Carrier state duration after onset of symptoms

~N(8, 5); lower limit = 4 days. I.e. time during which test
remains positive and patient can transmit infection.

Incubation period

~N(5, 5); lower limit = 2 days; 0% risk of transmitting
the disease in the first 2 days

% of tests that can become positive on a given day
(positivity rate)

25
âˆšð‘ƒ

+

20,000 âˆ™ ð´â€² 700,000,000 âˆ™ ð‘‡
âˆ’
ð‘ƒ .
ð‘ƒ

P = population size of the country. Aâ€™ = number of cases
diagnosed on the previous day. T = maximum number
of tests that can be done on that day.
Lower limit of 0.5%. Upper limit of 50%.
Maximum number of tests that can be done on a day

50 tests per day for 7 days after D days; then, 100 tests
daily for another 7 days; then, 200 tests daily for
another 7 days; then, 400 tests daily for another 7 days;
then, 500 tests each day

Infection fatality rate*

1.2%

% of people who are asymptomatic

5.0%

% of people who are mildly symptomatic

75%

% of people who are moderately symptomatic

13%

13

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

% of people who are severely ill

6.3%

% of asymptomatic people who visit the hospital

0%

% of mildly symptomatic people who visit the hospital

10%

% of moderately symptomatic people who visit the
hospital

80%

% of severely symptomatic people who visit the
hospital

90%

% of dying patients who visit the hospital

100%

% of infected people who get tested for SARS-CoV-2
after visiting the hospital

50% for 7 days after D days; 90% afterwards

% of quarantined people who get tested for SARSCoV-2

100%

Duration of treatment

~N(12, 2); lower limit of 8 days; treatment reduces the
duration of carrier state by 50% if the patient is still a
carrier at discharge

Duration of quarantine

14 days

Number of days needed to trace contacts

3 days

Table 1: Table summarizing the values of the variables used in the standard model. D = number of days needed to diagnose the
first couple of persons; for the standard model, D = 28 days. N(Î¼, Ïƒ) represents the normal distribution with mean Î¼ and standard
deviation Ïƒ. * These variables were manually modified to make the model fit the actual data. The â€œfirst dayâ€ is defined as the first
day when an infected person enters the country.

14

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Minimum and maximum number of infections diagnosed vs time compared
with actual number diagnosed
600
500
400
300
200
100

Total infections diagnosed (lowest value)

Total infections diagnosed (highest value)

Actual number of infections diagnosed

Mean diagnoses

12/4/20

11/4/20

9/4/20

10/4/20

8/4/20

7/4/20

6/4/20

5/4/20

4/4/20

3/4/20

2/4/20

1/4/20

31/3/20

30/3/20

29/3/20

28/3/20

27/3/20

26/3/20

25/3/20

24/3/20

23/3/20

22/3/20

21/3/20

20/3/20

19/3/20

18/3/20

17/3/20

16/3/20

15/3/20

0

Figure 2: Cumulative number of cases diagnosed in the country as predicted by the standard model

Minimum and maximum number of daily new cases diagnosed vs time
compared with actual number of new cases diagnosed
45
40
35
30
25
20
15
10
5

New diagnoses (lowest value)

New diagnoses (highest value)

12/4/20

11/4/20

10/4/20

9/4/20

8/4/20

7/4/20

6/4/20

5/4/20

4/4/20

3/4/20

2/4/20

1/4/20

31/3/20

30/3/20

29/3/20

28/3/20

27/3/20

26/3/20

25/3/20

24/3/20

23/3/20

22/3/20

21/3/20

20/3/20

19/3/20

18/3/20

17/3/20

16/3/20

15/3/20

0

Actual new diagnoses

Figure 3: Number of daily new cases diagnosed in the country as predicted by the standard model

15

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Total number of infections as predicted by the model
5000
4500
4000
3500
3000
2500
2000
1500
1000
500

Mean of total number of infections

12/4/20

10/4/20

8/4/20

6/4/20

4/4/20

2/4/20

31/3/20

29/3/20

27/3/20

25/3/20

23/3/20

21/3/20

19/3/20

17/3/20

15/3/20

13/3/20

11/3/20

9/3/20

7/3/20

5/3/20

3/3/20

1/3/20

28/2/20

26/2/20

24/2/20

22/2/20

20/2/20

18/2/20

0

2.5th percentile of the mean

97.5th percentile of the mean
Figure 4: Mean of the total number of infections in the country as predicted by the model

16

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Is a new respiratory outbreak of
national public health concern likely
to occur?

No action needed
No

Yes

Start training staff and buying
necessary equipment. Strengthen
the surveillance system and
reinforce the rapid response team.

Does the country have good testing
capabilities?

No

1.
2.

Yes

1.

2.
3.

4.

5.

Moderate
travel
restrictions
Test-based
POE screen
Isolate all
persons who
test positive
Monitor the
rest for Imax
days
Improve the
surveillance
system

No

Does the country have a good
surveillance system?

3.

*

4.

Yes

5.

Start population surveillance +/test-based POE screen â€¡

â€ 

No

Is their community transmission?
Yes

1.

Is an overwhelming surge likely?
Yes
No

1.
Disease is extinct,
eliminated or
eradicated worldwide
OR there is herd
immunity OR another
wave may occur

Cautious relaxation
of measures with
continued
surveillance

Strict travel
restrictions
Non-test-based
POE screen
Quarantine all
persons who
screen positive
Monitor the
rest for Imax days
Improve testing
capacity

2.
3.
4.

Maximize test and trace of
symptomatic persons and
possible reservoirs
Quarantine contacts and isolate
positive cases
Implement disease-specific
measures
Deploy FCR measures

Has the epidemy ended?
Yes

2.
3.

Â§

No

Maximize test
and treat of the
vulnerable / sick
population
Isolate positive
cases
Deploy UCR
measures

When R0 decreases,
start phased cutback
in UCR

Disease is endemic
or seasonally
epidemic

17

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Figure 5: Measures that should be considered when an outbreak might occur in a country. POE = point of entry and/or exit; I max is
the maximum duration of the incubation period or its 99 th percentile, whichever is more practical (Imax = 14 days for SARS-CoV-2);
R0 is the basic reproductive number; UCR = universal contact reduction; FCR = focused contact reduction. * = go to the next box
when testing capability is adequate or after Imax days has passed after time zero (in the latter situation, keep strict travel
restrictions until better testing capability is available); â€  = go to the next box when population surveillance is adequate or after
Imax days has passed after time zero (in the latter situation, keep moderate travel restrictions until better population surveillance
is carried out); â€¡ = carry out test-based POE screening if the anticipated surge of cases is likely to overwhelm the healthcare system;
Â§ = go to the next box when R0 is persistently and significantly less than 2. Time zero is the time when the country is most likely to
see its first infected person and in case this is too difficult to ascertain, it may be taken to be the time when the WHO declares a
Public Health Emergency of International Concern. To the extent possible, use a combination of strategies to have maximum effect.
See table 2 for details about the terms used in this figure.

Test and trace, POE screen with symptom-based monitoring, travel restriction and / or selective quarantine
Controlled
herd
immunity#

Specific UCR
(moderate
phase)

FCR

Restrictive
UCR*

Specific UCR (intense phase)

Re
0

1

2

3

4

5

Figure 6: Summary of strategies that may be used during the exponential phase of a COVID-19 epidemic. Factors other than just
the effective reproductive number should be considered before deciding which strategy to implement. POE â€“ point of entry or exit;
FCR â€“ focused contact reduction; UCR â€“ universal contact reduction. # - to implement if there is evidence of effective, long-term
immunity after the infection, the vulnerable part of the population can be properly protected and R e can be kept under 1.7. * - to
implement if benefits outweigh harms. Intense phase - â‰¥ 80% of the population should decrease their number of contacts by â‰¥
80%; moderate phase - â‰¥ 80% of the population should decrease their number of contacts by â‰¥ 60%. Test and trace work best
when applied early and when Re is less than 2. See main text regarding how to optimally use POE screen and travel restrictions.
For infections that have milder health impact, the graph should move to the right i.e. use more stringent measures when R e is
higher. See table 2 for details about the terms used in this figure.

18

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Terms
Respiratory outbreak

Comments
The model simulates outbreaks due to respiratory illnesses. The algorithm illustrated
in figure 5 should not be used for other infections that are transmitted by the fecaloral or vector-borne routes. These diseases require different measures to be
employed.

Outbreak of national
public health concern

Typically, this represents a new disease that is not already endemic in the country,
that can spread rapidly in the community and that can have a major economic and
health impact on the population. The country should raise the alert if it believes it is
vulnerable to such an infection.

Good testing capability

This implies that the country has in sufficient amount a test that is reasonably
sensitive and specific (typically more than 90% sensitive and more than 90% specific).
The number of tests needed varies depending on the reproductive number,
transmission duration, testing strategy used, health impact of the disease and
countermeasures in place. If the disease has low mortality and causes mild symptoms,
less people need to get tested. As a rough guide, initially, countries may prepare to
test about 20% of its population annually. Testing needs should be evaluated
regularly.

Travel restriction

Strict travel restriction means less than 1 infected person enters the country every
100 days while moderate travel restriction allows 1 infected person to enter the
country every 10 days. The benefits of restriction must be balanced with the economic
harm it can cause. Travel restrictions only delay entry of disease into the country by
about 2 to 4 mean incubation periods for every 10 days that an infected person is
prevented from entering the country. However, this strategy gives time for the
country to prepare itself and both strict and moderate restrictions reduce the burden
of disease early on by about 4 times. If a country has C known active carriers and a
population Pâ€™, then to allow 1 carrier to enter every N days, the destination country
should accept
persons daily; Câˆ™k represent the total number of carriers (including
âˆ™ âˆ™
the undiagnosed ones) and when this number is unclear, k may be estimated to be
10. Use of travel bubbles (travel bridges or Corona corridors) may help. For example,
France had 54,818 active cases on 1 June 2020 â€“ if N = 10, almost 100 passengers
could be allowed to enter the country from France every week (after point of entry or
exit screen).

Non-test-based point of
entry or exit screen

Point of entry and / or exit screen only delays the start of an outbreak and is less
effective than travel restrictions. Non-test-based screening focuses on patient
symptoms, temperature, and country of origin as well as countries recently visited
and other epidemiologic criteria. All travelers that come from countries where
community transmission is suspected or confirmed should be screened.

Test-based point of
entry or exit screen

Test-based screens utilize point-of-care lab tests that should preferably have more
than 90% sensitivity and more than 90% specificity. All travelers that come from
countries where community transmission is suspected or confirmed should get
tested. Due to the expense involved, use this type of screening only if the healthcare
system is unable to respond to the upcoming surge. Test-based screens can reduce
the number of infections early during the epidemy by about 3 times.

Quarantine

For practical reasons, selective quarantine is usually employed: people who are
recently in contact with confirmed or suspected cases are quarantined (self / home
or institutional). Symptomatic persons are isolated (self / home, institutional or
healthcare-based). If asymptomatic transmission is prevalent and the screening tool
has poor sensitivity, general quarantine may be considered within the limits of

19

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

acceptability i.e. all travelers from certain highly afflicted countries may be
quarantined. Institutionalized quarantine is preferred by some authorities, but this
must be balanced with the cost involved and the risk of enhanced transmission inside
an enclosed setting.
Monitoring of travelers

Travelers should get re-tested if they develop symptoms within the incubation period.
Monitoring can be active (whereby a healthcare worker checks on the person at a
certain frequency) or passive (= self-monitoring). If resources permit, active
monitoring is preferred.

Good population
surveillance system

Active (= sentinel) surveillance should be favored over passive surveillance. Usually,
syndromic surveillance is carried out; however, sewage testing and pool testing with
polymerase chain reaction can be useful. In this context, a good system should detect
the start and the extent of community transmission as early as possible. In situations
where asymptomatic, pre-symptomatic or mildly symptomatic patients can transmit
the infection effectively, a large number of people must be tested irrespective of
travel or contact history e.g. > 90% of patients with symptoms suggestive of the
infection should be tested even if epidemiologic criteria are not met since community
transmission will remain otherwise undetectable.

Overwhelming surge

This term suggests that the healthcare facilities may no longer be able to provide the
services needed to people who fall sick. The country should create models to estimate
under what conditions this is likely to occur. Accurate data must be collected daily
over the period of 1 to 2 (or more) mean incubation periods - as a rough estimate, if
Re is estimated to be greater than 3 or the doubling time is less than 7 days as well as
the number of free beds in the hospitals has dropped by more than 30% compared to
the usual number of free beds available during that time of the year, an overwhelming
surge may be imminent in that area. Under such circumstances, countries should
consider expanding the healthcare capacity to the maximum possible before applying
restrictive universal contact reduction.

Universal contact
reduction

Such measures can be divided into restrictive ones like lockdown (intermittent or
continuous; preventing people from getting out of their homes), confinement
(preventing people from getting out of an area) and curfew (preventing people from
getting out at certain times of the day), and specific ones like wearing of masks among
asymptomatic people or when in crowds, frequent hand sanitizing, unrestricted
gloving, regulating crowd size and universal social distancing. Restrictive UCR may be
considered when Re is too high (e.g. > 5) to control the outbreak using other strategies
(for an infection that can cause an unacceptable number of deaths or harm) or during
the early phase of the outbreak when transmission dynamics and epidemiological
characteristics are being elucidated.

Focused contact
reduction

Such measures include the closure of high-risk locations e.g. schools, universities or
some workplaces, shielding or cocooning the vulnerable segment of the population
(e.g. by wearing masks around them and social distancing from them), not coming to
work when having respiratory symptoms (i.e. using paid sick leaves), wearing masks
when symptomatic, working from home or tele-work, distancing from people who
cough, and applying good infection prevention and control within high-risk settings
like healthcare facilities.

Test and trace

When performed properly, more than 80% of patients who present with symptoms
suggestive of the disease should be tested, more than 250 tests should be done per
diagnosis (while community transmission is occurring) and more than 80% of contacts
should be traced and quarantined within 72 hours. If test and trace is started within

20

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

1 mean incubation period after the beginning of community transmission, the
chances of controlling the outbreak are particularly good. If this strategy is delayed,
the chances of success diminish considerably but Re may still be reduced by about
50% instead of 80%. This strategy fails when too few tests are performed. When the
incubation period is relatively short (e.g. < 1 month), testing of random asymptomatic
people is not practical since too many people need to get tested in too short a period
of time in order to have any effect on the outbreak.
Reservoirs

Reservoirs can include animals or vectors. Moreover, the poor and the marginalized
people in the society may not get tested nor treated appropriately; they can act as
reservoirs and prevent an outbreak from ending.

Phased cutback of
measures

Due to their impact on the economy, restrictive universal contact reduction measures
should be eased as soon as possible. When Re is around 2 consistently, contacts can
be reduced by only 50%; specific universal contact reduction may be used for this
purpose instead of restrictive ones; test and trace as well as focused contact reduction
should be emphasized when Re is less than 2 for 1 to 2 Imax (the maximum incubation
period). The use of social bubbles may help.

Disease-specific
measures

These measures can include immunization with a reasonably effective vaccine (and
with minimal side effects), early test and treat (to reduce the viral load which can then
decrease the transmission risk), pre-exposure prophylaxis or post-exposure
prophylaxis.

End of epidemy

The outbreak is considered to have ended if there are no active cases in the country
for the duration of 2 Imax days. To ensure this is the case, adequate testing must be
carried out.

Table 2: This table describes some of the terms used in figures 5 and 6. Numbers that are provided here should be used as a
guidance only. If some of the criteria cannot be fully met, then compensation should be sought in some other way e.g. if the
sensitivity of the test is much less than 90%, then much more than 80% of contacts should be traced.

21

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Appendix: Section A â€“ Justifications for the values of the variables used in the model
Variable

Value

Population size

The population of Mauritius in 2019 was 1,269,668 (1)

Rate of entry of infected people

The borders of Mauritius were closed soon after
COVID-19 cases were identified in the country

Sensitivity of point of entry screening

Quilty et al. describes a 64% sensitivity of screening for
SARS-CoV-2 at the airport (2)

Probability a person will transmit the infection

This was set so that the model gives a value of R0 equal
to about 3, which is a number frequently quoted in the
literature (3). This R0 is calculated from the infected
population at 28 days. The theoretical R0 calculated
from transmission data is otherwise 4.29 in the model.

Number of contacts per person per day in the
community without contact reduction

Mossong et al. suggests that people have a mean
number of 13 contacts per day in the community (4)

Contact reduction during quarantine

Assumption

Contact reduction during isolation

Assumption

Contact reduction when generalized public health
measures are taken

This was set so that the mean number of infections that
was diagnosed 1 month after the first case was
identified would be from 300 to 500.

% of population that are essential workers

Assumption

Sensitivity of test for SARS-CoV-2

Tests based on polymerase chain reaction (PCR) are
used to diagnose patients in Mauritius. The sensitivity
is unknown. While in-vitro sensitivity can be higher
than 95%, in-vivo sensitivity is much lower at 56% to
83% (5). Throat swabs may have a lower sensitivity of
32% compared to nasopharyngeal swabs (6). In
Mauritius, from March to April, most patients were
getting tested with throat swabs with each person
expected to get swabbed twice per test. Assuming a
sensitivity of 50%, a set of 2 such swabs can be said to
have a sensitivity of 75%.

% of infected patients who remain susceptible to the
virus

Song Tie, vice director of the local disease control
center in southern Chinaâ€™s Guangdong province
announced on 26 Feb 2020 that China has noted a reinfection rate of 14% (7)

% of contacts that are successfully traced

This was set so that the model accurately predicts the
number of diagnosed cases during the first month after
the first infected person is identified

Carrier state duration after onset of symptoms

According to the technical report from the European
Center for Disease Prevention and Control (ECDC), the
viral load of SARS-CoV-2 persists for 8 to 11 days after
symptom onset (8)

22

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Incubation period

The incubation period has been estimated to be from
4.5 days to 5.8 days, but some patients may develop
symptoms after 14 days (9)

% of tests that can become positive on a given day
(positivity rate)

After analyzing statistics on SARS-CoV-2 from the USA
and from Mauritius, an equation was empirically and
manually created to relate the positivity rate with the
size of the population, the number of cases diagnosed
and the number of tests performed. This equation may
not apply to other countries.

Maximum number of tests that can be done on a day

This was based on the actual number of tests that could
be carried out in Mauritius at the time.

Infection fatality rate

This was set to give a case fatality rate (number of
identified deaths from SARS-CoV-2 over total number
of cases diagnosed) of about 3% which is the mortality
rate observed in Mauritius at the time.

% of people who are asymptomatic

The ECDC suggests that the true asymptomatic rate
may be from 1% to 3% (10). This excludes presymptomatic or mildly symptomatic patients. Other
estimates can go up to 50% although it is likely that
these values include patients in the pre-symptomatic
phase (11).

% of people who are mildly symptomatic

About 80% of patients have mild symptoms according
to Worldometer (12)

% of people who are moderately symptomatic

2/3 of the people who remain (i.e. not asymptomatic
nor mildly symptomatic nor dying) were assumed to
have moderate symptoms in the model

% of people who are severely ill

The rest of infected patients have severe symptoms
(but do not die)

% of asymptomatic people who visit the hospital

Asymptomatic patients have no reason to visit the
hospital

% of mildly symptomatic people who visit the hospital

Patients with few symptoms rarely visit the hospital.

% of moderately symptomatic people who visit the
hospital

Most of these patients will visit the hospital

% of severely symptomatic people who visit the
hospital

Most of these patients will visit the hospital

% of dying patients who visit the hospital

All such patients will visit the hospital according to the
model (although there are reports of patients dying
without reaching any healthcare facilities)

% of infected people who get tested for SARS-CoV-2
after visiting the hospital

At the start of the outbreak, healthcare facilities were
still getting prepared and patients were not getting
tested as often as needed. Later, most patients with
respiratory symptoms were getting tested.

23

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

% of quarantined people who get tested for SARSCoV-2

All quarantined patients should get tested twice. This
was not the case initially in Mauritius but eventually
became the standard.

Duration of treatment

Many patients stayed in the hospital for about 14 days
in Mauritius. Patients were discharged only after 2
consecutive negative PCR tests. Xiao et al. noted that it
can take 17 to 24 days for the PCR to become negative
after onset of symptoms (13); it takes a few days after
the start of symptoms for patients to seek hospital care.
Fonfria et al. suggest the length of stay in the hospital
is from 13 days to 15 days (14).

Duration of quarantine

As per WHO recommendations, the duration of
quarantine is 14 days.

Number of days needed to trace contacts

Assumption

24

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Appendix: Section B â€“ Additional assumptions used in the model
1. The population remains static i.e. births, deaths and migration do not significantly affect the
number of people in the country due to the small changes involved.
2. 0% of the population has immunity to SARS-CoV-2 at the start of the outbreak.
3. All infected travelers who enter the country are assumed to be at the start of their incubation
period.
4. The transmission rate of the virus does not vary with time nor with symptoms in the model.
However, in reality, it is believed that patients who have more severe symptoms can transmit the
virus more effectively, while patients who are asymptomatic may be inept spreaders.
5. Risk of death of any person is the same i.e. demographic characteristics like age or co-morbidities
are not considered.
6. Transmission throughout the population is taken to be homogenous in the model. Nonetheless,
it is well established that networks exist within various regions of a country in which transmission
may be more proficient.

25

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Appendix: Section C â€“ Model structure
KEY

P
t=0

Update S, A and D
t â†’ t + 1 until t = tmax

S(t) : A(t) : D(t)

Q(t)

R(t, P0)

E(t)
I0 ~ âŒŠð‘âŒ‹
I0 â‰¥ 2
P(S0) = Î±
D0 ~ âŒŠð‘âŒ‹
D0 â‰¥ 4
T0 ~ âŒŠð‘âŒ‹
0.01 â‰¤ T0 â‰¤ 1
T0 = 0 for 1st 2d of E
P(Nâ€™) = Î²
P(T1) = É¤(t)
P(C0) = Î¸

Qâ€™(t)

P(S1) = Ïƒ

T2(t)
P(t, P1) = Î¼
I(t)
D1 ~ âŒŠð‘âŒ‹
D1 â‰¥ 8
D0 â†’ D0â€™

,

P2(P, Aâ€™, Tmax) =

âˆš

â‰¤ T2 â‰¤ Tmax
+

,

âˆ™
.

âˆ’

,

Tmax = Dâ€™ âˆ™ Aâ€™ in some cases
(T3 + 1) âˆ™ P1 â‰¤ Tmax
N0 â‰¤ Nmax
P(S2) = Ï•

C1(t)
C ~ âŒŠð‘âŒ‹
Câ‰¥0
F(t, C0, P3) = Ï†
C1 = F âˆ™ C
P(E) = T0

Iâ€™(t)

ïƒ¼
ïƒ¼
ïƒ¼
ïƒ¼

Active carrier
Dead
Cured and immune
Cured but not immune

,

âˆ™

ï¶ P = population size
ï¶ t = time in days (tmax is peak value of t)
ï¶ S = number people who are susceptible
ï¶ A = number of active carriers
ï¶ D = number of dead people
ï¶ E = people who are exposed and infected
ï¶ I0 = incubation period
ï¶ ~ N = normal distribution
ï¶ âŒŠð‘¥âŒ‹ = floor function
ï¶ P(x) = probability of x occurring
ï¶ S0 = severity index (asymptomatic, mild symptoms,
etc.)
ï¶ D0 = carrier state duration
ï¶ T0 = probability of transmission per contact
ï¶ N' = probability non-immune after infection
ï¶ T1 = probability a contact is traced
ï¶ C0 = characteristic index (being poor or an essential
worker)
ï¶ R = number of infected travelers getting in per day
ï¶ P0 = policies in place (e.g. travel restrictions)
ï¶ S1 = sensitivity of POE screen
ï¶ Q = people in quarantine
ï¶ Qâ€™ = people getting out of quarantine after 14 days
if still a carrier without being diagnosed
ï¶ T2 = number of tests done in a day
ï¶ P1 = policies in place (e.g. which patients get tested;
population surveillance, etc.)
ï¶ Tmax = maximum number of tests that can be done
on a day
ï¶ P2 = positivity rate
ï¶ Aâ€™ = number of cases diagnosed on the previous
day
ï¶ Dâ€™ = diagnostic rate
ï¶ T3 = number of tests done on infected patients / d
ï¶ N0 = number of tests done on a patient
ï¶ Nmax = maximum number of tests that can be done
on a patient
ï¶ S2 = probability a test being positive (sensitivity)
ï¶ I = people in isolation
ï¶ D1 = Treatment duration
ï¶ D0â€™ = new carrier state duration
ï¶ Iâ€™ = people getting out of isolation but still a carrier
ï¶ C1 = number of contacts per person
ï¶ C = number of contacts per person without any
policies in place
ï¶ F = fraction by which contacts get reduced due to
policies in place
ï¶ P3 = policies in place (e.g. lockdown, isolation, etc.)

Figure 7: The mathematical and programmatic structure of the standard model. See the main article for values and definitions of variables. When a
variable that follows a probability distribution exceeds its limits, it is approximated to the nearest bound. Q(t) includes patients who are screened
positive through S1 or through contact tracing T1. I(t) includes people who are tested positive. Patients remain a carrier at least till the end of treatment
(if treated). POE = point of entry or exit. Calculated reproductive number at time t = number of secondary infections from people who are no longer
carriers (including dead people) at time t / total number of these people at time t.

26

medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20134130; this version posted June 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

References
1. https://www.worldometers.info/world-population/mauritius-population/ Accessed on 11 June 2020.
2. Quilty BJ, Clifford S, Cmmid nCoV Working Group, Flasche S and Eggo RM. Effectiveness of airport screening at detecting
travellers infected with novel coronavirus (2019-nCoV). Euro Surveill. 2020 Feb;25(5).

3. Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China,
from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214-217.

4. Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.

2008;5(3):e74.
Kokkinakis I, Selby K, Favrat B, Genton B and Cornuz J. Performance du frottis nasopharyngÃ©-PCR pour le diagnostic du Covid19 - Recommandations pratiques sur la base des premiÃ¨res donnÃ©es scientifiques [Covid-19 diagnosis : clinical
recommendations and performance of nasopharyngeal swab-PCR]. Rev Med Suisse. 2020;16(689):699-701.
Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020;323(18):1843â€“
1844.
https://english.kyodonews.net/news/2020/02/944f1f45d408-virus-deaths-in-china-top-2700-total-infection-cases-exceed78000.html Accessed 12 June 2020
European Center for Disease Prevention and Control. Guidance for discharge and ending isolation in the context of
widespread community transmission of COVID-19 â€“ first update. 8 April 2020.
Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported
Confirmed Cases: Estimation and Application. Ann Intern Med. 2020;172(9):577-582.
European Center for Disease Prevention and Control. Novel coronavirus disease 2019 (COVID-19) pandemic: increased
transmission in the EU/EEA and the UK â€“ sixth update. 12 March 2020.
https://www.reuters.com/article/us-health-coronavirus-singapore-wong-exc/exclusive-half-of-singapores-new-covid-19cases-are-symptomless-taskforce-head-says-idUSKBN23F0ZY Accessed on 12 June 2020.
https://www.worldometers.info/coronavirus/coronavirus-symptoms/ Accessed 12 June 2020.
Xiao AT, Tong YX, Gao C et al. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive
study. J Clin Virol. 2020;127:104346.
Fonfria E, Vigo MI, Garcia-Garcia D, et al. Essential epidemiological parameters of COVID-19 for clinical and mathematical
modeling purposes: a rapid review and meta-analysis. medRxiv 2020.06.17.20133587.

27

